New drug cocktail aims to tame lupus kidney flares

NCT ID NCT07225387

Recruiting now Disease control Sponsor: NephroNet, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether combining two medications, belimumab and voclosporin, along with standard therapy, can help more people with lupus-related kidney disease achieve complete remission. About 30 adults with active lupus nephritis will take part. The goal is to see if this combo improves kidney function and allows patients to stop one of the usual drugs sooner.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUPUS NEPHRITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lupus nephritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LUPUS NEPHRITIS

Contacts and locations

Locations

AARA Clinical Research
RECRUITING

Glendale, Arizona, 85306, United States
AARA Clinical Research
RECRUITING

Fort Worth, Texas, 76109, United States
Georgia Nephrology Research Institute
RECRUITING

Lawrenceville, Georgia, 30046, United States
Nephrology Clinical Trials Unit The Ohio State University Wexner Medical Center
RECRUITING

Columbus, Ohio, 43201, United States
Oklahoma Medical Research Foundation
RECRUITING

Oklahoma City, Oklahoma, 73104, United States
Parris & Associates
RECRUITING

Lawrenceville, Georgia, 30046, United States
Piedmont Physicians Rheumatology
RECRUITING

Atlanta, Georgia, 30318, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.